
Colleen Erin Snow
Examiner (ID: 14817, Phone: (571)272-8603 , Office: P/2899 )
| Most Active Art Unit | 2899 |
| Art Unit(s) | 2813, 2899 |
| Total Applications | 852 |
| Issued Applications | 644 |
| Pending Applications | 44 |
| Abandoned Applications | 177 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12159281
[patent_doc_number] => 20180030548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'POINT MUTATIONS IN TRK INHIBITOR-RESISTANT CANCER AND METHODS RELATING TO THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/785174
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 104655
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15785174
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/785174 | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same | Oct 15, 2017 | Issued |
Array
(
[id] => 12159282
[patent_doc_number] => 20180030549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'POINT MUTATIONS IN TRK INHIBITOR-RESISTANT CANCER AND METHODS RELATING TO THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/785228
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 104326
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15785228
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/785228 | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same | Oct 15, 2017 | Issued |
Array
(
[id] => 12682186
[patent_doc_number] => 20180119228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => POINT MUTATIONS IN TRK INHIBITOR-RESISTANT CANCER AND METHODS RELATING TO THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/785218
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15785218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/785218 | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same | Oct 15, 2017 | Issued |
Array
(
[id] => 12184012
[patent_doc_number] => 20180042947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 15/782480
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 47325
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782480
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/782480 | Neridronic acid for treating complex regional pain syndrome | Oct 11, 2017 | Issued |
Array
(
[id] => 12157238
[patent_doc_number] => 20180028503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder'
[patent_app_type] => utility
[patent_app_number] => 15/729692
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12675
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15729692
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/729692 | Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder | Oct 10, 2017 | Abandoned |
Array
(
[id] => 12157239
[patent_doc_number] => 20180028504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder'
[patent_app_type] => utility
[patent_app_number] => 15/730288
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12672
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15730288
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/730288 | Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder | Oct 10, 2017 | Abandoned |
Array
(
[id] => 14682223
[patent_doc_number] => 20190240226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH
[patent_app_type] => utility
[patent_app_number] => 16/343566
[patent_app_country] => US
[patent_app_date] => 2017-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343566
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343566 | Anti-proliferative agents for treating PAH | Oct 8, 2017 | Issued |
Array
(
[id] => 15320825
[patent_doc_number] => 20200000742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => COMBINATION
[patent_app_type] => utility
[patent_app_number] => 16/334002
[patent_app_country] => US
[patent_app_date] => 2017-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334002
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/334002 | COMBINATION | Oct 4, 2017 | Abandoned |
Array
(
[id] => 12603153
[patent_doc_number] => 20180092881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder
[patent_app_type] => utility
[patent_app_number] => 15/723391
[patent_app_country] => US
[patent_app_date] => 2017-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15723391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/723391 | Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder | Oct 2, 2017 | Abandoned |
Array
(
[id] => 12150092
[patent_doc_number] => 20180021356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'Treating Vitamin D Insufficiency and Deficiency With 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3'
[patent_app_type] => utility
[patent_app_number] => 15/722757
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8769
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15722757
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/722757 | Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D | Oct 1, 2017 | Issued |
Array
(
[id] => 13440583
[patent_doc_number] => 20180271834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => PHYTOESTROGEN COMPOSITIONS AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 15/721424
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721424
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721424 | Phytoestrogen compositions and associated methods | Sep 28, 2017 | Issued |
Array
(
[id] => 13297443
[patent_doc_number] => 20180200258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => METHODS FOR TREATING GI TRACT DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/717765
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15717765
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/717765 | METHODS FOR TREATING GI TRACT DISORDERS | Sep 26, 2017 | Abandoned |
Array
(
[id] => 17648428
[patent_doc_number] => 11351127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 16/334835
[patent_app_country] => US
[patent_app_date] => 2017-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9058
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334835
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/334835 | Pharmaceutical composition | Sep 20, 2017 | Issued |
Array
(
[id] => 13125701
[patent_doc_number] => 10080765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Neridronic acid for treating complex regional pain syndrome
[patent_app_type] => utility
[patent_app_number] => 15/710759
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 43645
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15710759
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/710759 | Neridronic acid for treating complex regional pain syndrome | Sep 19, 2017 | Issued |
Array
(
[id] => 13339681
[patent_doc_number] => 20180221380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => Use of 5H-Dibenz/b,f/Azepine-5-Carboxamide Derivatives for Treating Fibromyalgia
[patent_app_type] => utility
[patent_app_number] => 15/710173
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15710173
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/710173 | Use of 5H-Dibenz/b,f/Azepine-5-Carboxamide Derivatives for Treating Fibromyalgia | Sep 19, 2017 | Abandoned |
Array
(
[id] => 12238348
[patent_doc_number] => 20180071211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'TOPICAL CORTICOSTEROIDS FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT'
[patent_app_type] => utility
[patent_app_number] => 15/707961
[patent_app_country] => US
[patent_app_date] => 2017-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20500
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15707961
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/707961 | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract | Sep 17, 2017 | Issued |
Array
(
[id] => 16009089
[patent_doc_number] => 20200179387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => USES OF SALT-INDUCIBLE KINASE (SIK) INHIBITORS FOR TREATING OSTEOPOROSIS
[patent_app_type] => utility
[patent_app_number] => 16/333546
[patent_app_country] => US
[patent_app_date] => 2017-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -77
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333546 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | Sep 15, 2017 | Issued |
Array
(
[id] => 14743789
[patent_doc_number] => 20190255068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => PROSTACYCLIN ANALOGUE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/333448
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333448
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333448 | Prostacyclin analogue formulations | Sep 14, 2017 | Issued |
Array
(
[id] => 15206101
[patent_doc_number] => 20190365737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/332033
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332033
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332033 | Pharmaceutical composition | Sep 12, 2017 | Issued |
Array
(
[id] => 12117253
[patent_doc_number] => 20180000840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'Methods And Compositions For Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 15/703773
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8332
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703773
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/703773 | Methods and compositions for treating cancer | Sep 12, 2017 | Issued |